Magdalena Knetki-Wróblewska

14PUBLICATIONS
18CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical physicsSolid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 26, 2026
Prevention and Management of Dermatologic Adverse Events in Patients Treated with Amivantamab Plus Lazertinib.

Carolyn Szwed, Leszek Blicharz, Magdalena Knetki-Wroblewska

|Feb 11, 2026
State of the art of perioperative assessment in early non-small-cell lung cancer in Poland in the emerging era of perioperative protocols.

Tomasz Marjanski, Magdalena Knetki-Wroblewska, Lukasz Kuncman

|Jan 20, 2025
Emerging insights into STK11, KEAP1 and KRAS mutations: implications for immunotherapy in patients with advanced non-small cell lung cancer.

Magdalena Knetki-Wróblewska, Kamila Wojas-Krawczyk, Paweł Krawczyk

|Aug 28, 2024
Pulmonary Benign Metastasizing Leiomyoma in a Postmenopausal Woman: A Case Report and Review of the Literature.

Aleksandra Piórek, Adam Płużański, Piotr Wiśniewski

|Mar 02, 2024
Clinicopathological characteristics of patients with primary tracheal tumors: Analysis of eighty-nine cases.

Aleksandra Piórek, Adam Płużański, Paweł Teterycz

|Mar 29, 2023
Nivolumab or Atezolizumab in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer? A Prognostic Index Based on Data from Daily Practice.

Magdalena Knetki-Wróblewska, Sylwia Tabor, Aleksandra Piórek

Pageof 3

Frequent Collaborators

6 joint publications

Dariusz M Kowalski

4 joint publications

Adam Płużański

4 joint publications

Aleksandra Piórek

2 joint publications

Kamila Wojas-Krawczyk